This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
OTC Markets Group Inc. (OTCM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
OTC Markets Group Inc. (OTCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cboe Global (CBOE) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Cboe Global's (CBOE) Q2 results are likely to reflect higher access fees in the Europe and Asia Pacific segment, greater financial risk analytics market data and growth in multi-listed options trading.
CBOE (CBOE) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
CBOE (CBOE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
CBOE Global (CBOE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CBOE (CBOE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) Beats on Q2 Earnings, Tightens Expense View
by Zacks Equity Research
Nasdaq (NDAQ) Q2 earnings reflect solid performance of both segments.
Here's Why CBOE Global (CBOE) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does CBOE Global (CBOE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks.com featured highlights include AMN Healthcare Services, Otter Tail, Encore Capital Group and Cboe Global Markets
by Zacks Equity Research
AMN Healthcare Services, Otter Tail, Encore Capital Group and Cboe Global Markets are part of zacks Screen of the week article.
4 Stocks Trading Near 52-Week High That Can Scale Higher
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like AMN, OTTR, ECPG and CBOE that are seeing price strength have a high chance of carrying the momentum forward.
3 Reasons Growth Investors Will Love CBOE (CBOE)
by Zacks Equity Research
CBOE (CBOE) could produce exceptional returns because of its solid growth attributes.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why You Should Stay Invested in Cboe Global (CBOE) Stock
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products and solid capital position poise Cboe Global (CBOE) well for growth.
Cboe Global (CBOE) Inks Deal With Validus to Create Indices
by Zacks Equity Research
Cboe Global (CBOE) signs an agreement with Validus to develop new indexes and products.
Why CBOE Global (CBOE) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Hold is an Apt Strategy for Cboe Global (CBOE) Stock Now
by Zacks Equity Research
Strong market position, global reach, strength in its proprietary products, solid capital position poise Cboe Global (CBOE) well for growth.
Why CBOE Global (CBOE) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Owl Rock Capital (ORCC) Down 10% as Q1 Earnings Miss Estimates
by Zacks Equity Research
Owl Rock Capital's (ORCC) first-quarter earnings hurt by higher operating expenses, partly offset by increased dividend income leading to better investment income.
Cboe Global (CBOE) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Cboe Global (CBOE) Q1 results reflect higher net transaction and clearing fees, access and capacity fees, and market data, offset by higher expenses.
CBOE Global (CBOE) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
CBOE (CBOE) delivered earnings and revenue surprises of 3.59% and 2.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cboe Global (CBOE) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Cboe Global's (CBOE) first-quarter results are likely to reflect higher demand for data and access solutions, strong proprietary products and contribution from acquisitions.
CBOE Global (CBOE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CBOE (CBOE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Cboe Global Markets, Nasdaq and MarketAxess have been highlighted in this Industry Outlook article.
5 Securities and Exchanges in Focus Despite Industry Headwinds
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
Nasdaq (NDAQ) Beats on Q1 Earnings, Tweaks Expense View
by Zacks Equity Research
Nasdaq's (NDAQ) Q1 performance reflect solid results at the Solutions segment.
Nasdaq (NDAQ) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Nasdaq (NDAQ) delivered earnings and revenue surprises of 2.07% and 0.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Hold On to Cboe Global (CBOE) Stock
by Zacks Equity Research
Cboe Global (CBOE) is set to grow on organic growth in access and capacity fees and proprietary market data fees and solid capital position.